Sex and androgenic steroid receptor expression in hepatic adenomas

作者: Cynthia Cohen , Diane Lawson , Patricia B DeRose

DOI: 10.1016/S0046-8177(98)90011-9

关键词:

摘要: Sex hormones and anabolic-androgenic steroids are implicated in the development progression of hepatic adenomas (HA). We studied expression their receptors HA adjacent liver. Archival tissue sections 27 (16 resections, four needle biopsies, seven aspirations) from 18 patients, liver, were immunostained with monoclonal antibody to estrogen receptor (ER, 1/80) (Dako, Carpinteria, CA), progesterone (PR, 1/50) (BioGenex, San Ramon, androgen (AR, (BioGenex). An avidin-biotin complex technique was used microwave antigen retrieval. Nuclear assessed as 1+ 3+ intensity, semiquantitation percentage nuclei immunopositive. Five percent or more immunopositive regarded positive. The patients included 16 females 34 years mean age (range, 49) an available history oral contraceptives five; two men 24 30 years, no androgenic steroids. ER, PR, AR present (26%) (1+/-2+ 5% 10% nuclei) HA, 30% nine (33%) (1+/-3+ 80% nuclei), respectively. In liver 11 cases, there one (9%) (2+ (36%) PR 20% (18%) (2+/-3+ nuclei). Receptors may mediate action sex on but less than third patients. This have therapeutic implications.

参考文章(38)
Gerald Klatskin, Hepatic tumors: possible relationship to use of oral contraceptives. Gastroenterology. ,vol. 73, pp. 386- 394 ,(1977) , 10.1016/S0016-5085(19)32205-X
Pitot Hc, Sattler Ca, Sargent Lm, Wiley Je, Schroeder P, Sattler Gl, Dragan Yp, Bahnub N, Jordan Vc, Tamoxifen induces hepatic aneuploidy and mitotic spindle disruption after a single in vivo administration to female Sprague-Dawley rats. Cancer Research. ,vol. 54, pp. 3357- 3360 ,(1994)
Elizabeth A. Saffer, Nurten Gunduz, Bernard Fisher, Shu Zheng, Relation of Estrogen and Its Receptor to Rat Liver Growth and Regeneration Cancer Research. ,vol. 44, pp. 2410- 2415 ,(1984)
Naofumi Nagasue, Akio Ito, Hirofumi Yukaya, Yuichiro Ogawa, Androgen receptors in hepatocellular carcinoma and surrounding parenchyma. Gastroenterology. ,vol. 89, pp. 643- 647 ,(1985) , 10.1016/0016-5085(85)90463-9
Lynne E. Porter, Mary S. Elm, David H. Van Thiel, Patricia K. Eagon, Hepatic estrogen receptor in human liver disease Gastroenterology. ,vol. 92, pp. 735- 745 ,(1987) , 10.1016/0016-5085(87)90026-6
Kamal G. Ishak, Hepatic Neoplasms Associated with Contraceptive and Anabolic Steroids Recent results in cancer research. ,vol. 66, pp. 73- 128 ,(1979) , 10.1007/978-3-642-81267-5_3
NAOFUMI NAGASUE, YU-CHUNG CHANG, TAKAFUMI HAYASHI, GENNARO GALIZIA, HITOSHI KOHNO, TERUHISA NAKAMURA, HIROFUMI YUKAYA, Androgen receptor in hepatocellular carcinoma as a prognostic factor after hepatic resection Annals of Surgery. ,vol. 209, pp. 424- 427 ,(1989) , 10.1097/00000658-198904000-00006
Naofumi Nagasue, Hitoshi Kohno, Akira Yamanoi, Takeo Kimoto, Yu-Chung Chang, Teruhisa Nakamura, Progesterone receptor in hepatocellular carcinoma. Correlation with androgen and estrogen receptors. Cancer. ,vol. 67, pp. 2501- 2505 ,(1991) , 10.1002/1097-0142(19910515)67:10<2501::AID-CNCR2820671019>3.0.CO;2-N
HUGH A. EDMONDSON, Regression of Liver Cell Adenomas Associated with Oral Contraceptives Annals of Internal Medicine. ,vol. 86, pp. 180- 182 ,(1977) , 10.7326/0003-4819-86-2-180